GARCIA RUBEN A 4

What Happened

• Ruben A. Garcia, General Counsel of FibroBiologics, purchased 40,000 shares of FBLG in open-market transactions on February 27, 2026. The reported weighted average price was $0.33 per share for a total reported value of $13,056. This was a purchase (insider buy), not a sale.

Key Details

• Transaction date: 2026-02-27 (reported on Form 4 filed 2026-03-02)
• Transaction type/code: Open-market purchase (P)
• Price: weighted avg $0.33 per share (total $13,056)
• Price range (footnote): individual trades ranged from $0.3221 to $0.3268 on Feb 27, 2026; the filer can provide per-trade detail on request
• Shares owned after transaction: Not specified in the provided filing
• Filing timeliness: Form 4 filed on Mar 2, 2026 for a Feb 27 trade — appears to be filed within the normal Form 4 reporting window

Context

• Insider purchases can be of interest to retail investors as one data point of insider sentiment, but they do not by themselves indicate a definitive view of company prospects. This filing reports an open-market buy by the company’s general counsel; no options exercise, award, or gift was involved.